OAM
CALA

Oxford Asset Management’s Calithera Biosciences, Inc CALA Stock Holding History

Oxford Asset Management’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-6,186
Closed -$706K – 1544
2019
Q4 		$706K Sell
6,186
-5,635
-48% -$424K 0.02% 1054
2019
Q3 		$731K Buy
11,821
+4,539
+62% +$363K 0.02% 1098
2019
Q2 		$568K Sell
7,282
-4,176
-36% -$474K 0.01% 1225
2019
Q1 		$1.54M Buy
11,458
+6,594
+136% +$693K 0.03% 719
2018
Q4 		$390K Buy
+4,864
New +$480K 0.01% 1298
2018
Q2 		– Sell
-545
Closed -$69K – 1998
2018
Q1 		$69K Sell
545
-6,604
-92% -$1.03M ﹤0.01% 1549
2017
Q4 		$1.19M Buy
+7,149
New +$1.83M 0.03% 845
2017
Q2 		– Sell
-1,411
Closed -$326K – 1763
2017
Q1 		$326K Sell
1,411
-1,064
-43% -$184K 0.01% 1175
2016
Q4 		$161K Buy
+2,475
New +$155K 0.01% 714

Other funds holding CALA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Oxford Asset Management's CALA Position: Q1 2020 in Review

Oxford Asset Management sold out of Calithera Biosciences, Inc (CALA) in Q1 2020, closing a stake of 6,186 shares — an estimated $706K sold.

Oxford Asset Management first reported a position in CALA in Q4 2016 and held it in 9 quarters. The position peaked at $1.54M in Q1 2019. 80 funds tracked by Wall St. Rank hold CALA as of Q1 2020.

  • Oxford Asset Management reported no remaining Calithera Biosciences, Inc position as of Q1 2020 after selling out during the quarter.
  • Oxford Asset Management sold 6,186 Calithera Biosciences, Inc shares in Q1 2020, an estimated $706K.
  • Oxford Asset Management first reported a position in Calithera Biosciences, Inc in Q4 2016 and held it in 9 quarters.
  • Oxford Asset Management's Calithera Biosciences, Inc position peaked at $1.54M in Q1 2019.
  • 80 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q1 2020.

Based on Oxford Asset Management's 13F filing for Q1 2020, filed 15 May 2020.